Skip to main content
Fig. 7 | BMC Medical Genomics

Fig. 7

From: Pan-cancer analysis of the prognostic and immunological role of SNX29: a potential target for survival and immunotherapy

Fig. 7

Relationship between ICB treatment response and SNX29 expression by TIDE. Relationship between ICB treatment response in TIDE and SNX29 expression. Low expression of SNX29 was strongly associated with ICB response, including A BLCA, B GBM, C HNSC, D LAML, E LUAD, F THCA, G SARC, H SKCM, H THYM and J STAD. High expression of SNX29 was negatively correlated with ICB response, including K KIRC and L LGG

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us